Can-Fite has received agreement from both the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) on the current pivotal Phase 3 clinical study RAMAT GAN, Israel, May 13, 2024...
Source LinkCan-Fite has received agreement from both the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) on the current pivotal Phase 3 clinical study RAMAT GAN, Israel, May 13, 2024...
Source Link
Comments